1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Philips NV
  6. News
  7. Summary
    PHIA   NL0000009538


Real-time Euronext Amsterdam  -  05/24 11:38:04 am EDT
23.28 EUR   -1.13%
05:18aPHILIPS : Respironics provides update on filed MDRs in connection with the voluntary recall notification/field safety notice* for specific CPAP, BiPAP and mechanical ventilator devices
05/20PHILIPS NV : JP Morgan reiterates its Neutral rating
05/17Royal Philips - New release of Philips EchoNavigator helps interventional teams treat structural heart disease with greater ease and efficiency
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Philips integrates cloud-based AI and 3D mapping into its Mobile C-arm System Series – Zenition – to enhance workflow efficiency and improve endovascular treatment outcomes

01/18/2022 | 04:00am EDT

January 18, 2021

  • New capabilities on Philips Image Guided Therapy Mobile C-arm System – Zenition – and collaboration with Cydar offer the latest advances in endovascular treatment
  • Partnership adds new innovations to the Zenition platform to elevate the clinical experience, enhance workflow efficiency and help improve patient outcomes

Amsterdam, the Netherlands Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced physicians will now have access to advanced new 3D image guidance capabilities through its Image-Guided Therapy Mobile C-arm System – Zenition, delivering enhanced clinical accuracy and efficiency, and aiming to improve the outcomes for patients undergoing endovascular treatment. The company has signed a strategic partnership agreement with Cydar, a UK-based provider of cloud-based procedure maps software to plan and guide surgery in real time.

As patient numbers rise and procedures become more complex and time-consuming, patient-specific real-time procedure planning and guidance, optimization of equipment utilization, and usability have become ever more important. To help overcome these challenges, Philips Image-Guided Therapy Mobile C-arm System – Zenition – brings together innovations in image capture and processing, ease-of-use, and versatility, many of which were pioneered on Philips’ highly successful image guided therapy platform Azurion. Like Azurion, the Zenition mobile C-arm system allows hospitals to maximize operating room performance, enhance their clinical capabilities, and provide staff with a seamless user experience. The integration of Cydar EV Maps software into the Zenition platform now adds extended procedure planning and real-time 3D guidance capabilities.

Cloud-based AI and computer vision
Cydar EV Maps assists in the planning, real-time guidance, and post procedure review of endovascular surgery. It brings cloud-based AI and computer vision to mobile surgery, enabling reductions in radiation exposure, fluoroscopy time, and procedure time together with improved ease of use [1,2]. It enables surgeons to create a detailed patient-specific 3D map of the target vasculature to help plan surgery, and then uses these maps to augment intraoperative live image-guidance, updating the maps in real time to account for deformations during surgery, such as guidewires and instruments deforming the patient’s blood vessels. Cydar EV also facilitates post procedure outcome analysis. The combined result of this integration of procedure planning, guidance and review is that surgeons can work more accurately and efficiently – enabling an approximate 50% reduction in radiation exposure [1], a significant reduction in fluoroscopy time and a reduction of procedure times by more than 20% [2], while helping achieve better outcomes for patients.

“With Philips’ integrated portfolio, using validated AI and cloud technologies, we can facilitate collaborative care to optimize surgical pathways,” said Karim Boussebaa, General Manager Image Guided Therapy Systems at Philips. “Philips has a strong global network of mobile surgery systems and recognizes that Cydar’s EV Maps solution can play a key role in further improving our integrated offering for endovascular procedures.”

“By partnering with Philips to bring our Cydar EV Maps solution to Philips’ user-friendly Zenition platform of mobile C-arms, we are a step closer to achieving our mission to ensure every image-guided minimally-invasive surgical procedure goes exactly as planned,” said Paul Mussenden, CEO of Cydar. “The benefits of this combined solution, with integrated and enhanced procedure planning and visualization, include shorter and more predictable procedure times, reduced X-ray exposure to patients and staff, and fewer injections of iodine dye - the leading cause of in-hospital kidney failure.”

Cydar EV Maps is currently in use across the EU, UK and US. It is certified Software-as-a-Medical Device with EU CE mark and U.S. FDA 510(k) clearances.

[1] Southerland K, Nag U, Turner M, Gilmore B, McCann R, Long C, Cox M, Shortell C. IF09. Image-Based Three-Dimensional Fusion Computed Tomography Decreases Radiation Exposure, Fluoroscopy Time, and Procedure Time During Endovascular Aortic Aneurysm Repair. J Vasc Surg. 2018;67: e61-e61
[2] Shortell C., Veith Symposium New York, 2017

For further information, please contact:

Joost Maltha 
Philips Global Press Office 
Tel: +31 6 10 55 8116  
Email: joost.maltha@philips.com

Fabienne van der Feer
Philips Image Guided Therapy
Tel: + 31 622 698 001
E-mail: fabienne.van.der.feer@philips.com

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2020 sales of EUR 17.3 billion and employs approximately 78,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

About Cydar
Cydar Limited specializes in medical computer vision, machine learning and cloud high-performance computing.  Cydar EV is a cloud-based software platform that generates patient specific 3D Maps of soft tissue vasculature to support more effective image guided, minimally invasive endovascular surgery. The system comprises pre-operative procedure planning functionality and real time, AI enabled 3D intra-operative imaging and procedure guidance, with procedure video capture and post procedure review functions.
Cydar EV Maps harnesses the latest in cloud GPU computing, computer vision and machine learning technology to advance surgical visualization and decision-making in theatre and across the surgical pathway. Cydar’s Surgical Intelligence system is learning from every case to develop a deeper understanding of surgery.
Headquartered in Cambridge, UK, Cydar’s focus is to build a future where all patients benefit from augmented surgical intelligence.  Cydar EV Maps is the first product from Cydar’s Intelligent Maps system.


  • Philips Zention mobile C-arm platform vascular application
  • Cydar EV Maps

Primary Logo

Source: Royal Philips

2022 GlobeNewswire, Inc., source Press Releases

All news about PHILIPS NV
05:18aPHILIPS : Respironics provides update on filed MDRs in connection with the voluntary recal..
05/20PHILIPS NV : JP Morgan reiterates its Neutral rating
05/17Royal Philips - New release of Philips EchoNavigator helps interventional teams treat s..
05/16Philips showcases ultra-low contrast PCI solutions at EuroPCR 2022
05/16Philips showcases ultra-low contrast PCI solutions at EuroPCR 2022
05/16New release of Philips EchoNavigator helps interventional teams treat structural heart ..
05/16Koninklijke Philips N.V. Announces the International Launch of EchoNavigator 4.0 at Eur..
05/12PHILIPS NV : Ex-dividend day for final dividend (optional)
05/10Shareholders Vote Down Philips' Executive Compensation Plan
05/10Philips Annual General Meeting of Shareholders approves dividend and other proposals ma..
More news
Analyst Recommendations on PHILIPS NV
More recommendations
Sales 2022 18 272 M 19 605 M 19 605 M
Net income 2022 806 M 865 M 865 M
Net Debt 2022 4 281 M 4 594 M 4 594 M
P/E ratio 2022 24,1x
Yield 2022 3,73%
Capitalization 20 237 M 21 714 M 21 714 M
EV / Sales 2022 1,34x
EV / Sales 2023 1,25x
Nbr of Employees 78 189
Free-Float 97,5%
Duration : Period :
Philips NV Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PHILIPS NV
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 23,28 €
Average target price 31,99 €
Spread / Average Target 37,4%
EPS Revisions
Managers and Directors
Frans van Houten Chief Executive Officer
Abhijit Bhattacharya Chief Financial Officer & Executive Vice President
Feike Sijbesma Chairman-Supervisory Board
Jan Kimpen Chief Medical Officer
Sophie Bechu Chief Operating Officer & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
PHILIPS NV-28.14%21 872